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Abstract
Background: To describe the dietary intake of participants in the Personalized Medicine Research Project (PMRP),
and to quantify differences in nutrient intake by smoking status and APOE4-a genetic marker that has been shown
to modify the association between risk factors and outcomes.
Methods: The PMRP is a population-based DNA, plasma and serum biobank of more than 20,000 adults aged 18
years and older in central Wisconsin. A questionnaire at enrollment captures demographic information as well as
self-reported smoking and alcohol intake. The protocol was amended to include the collection of dietary intake
and physical activity via self-reported questionnaires: the National Cancer Institute 124-item Diet History
Questionnaire and the Baecke Physical Activity Questionnaire. These questionnaires were mailed out to previously
enrolled participants. APOE was genotyped in all subjects.
Results: The response rate to the mailed questionnaires was 68.2% for subjects who could still be contacted (alive
with known address). Participants ranged in age from 18 to 98 years (mean 54.7) and 61% were female. Dietary
intake is variable when comparing gender, age, smoking, and APOE4. Over 50% of females are dietary supplement
users; females have higher supplement intake than males, but both have increasing supplement use as age
increases. Food energy, total fat, cholesterol, protein, and alcohol intake decreases as both males and females age.
Female smokers had higher macronutrient intake, whereas male nonsmokers had higher macronutrient intake.
Nonsmokers in both genders use more supplements. In females, nonsmokers and smokers with APOE4 had higher
supplement use. In males, nonsmokers with APOE4 had higher supplement use between ages 18-39 only, and
lower supplement use at ages above 39. Male smokers with APOE4 had lower supplement use.
Conclusion: Dietary intake in PMRP subjects is relatively consistent with data from the National Health and
Nutrition Examination Survey (NHANES). Findings suggest a possible correlation between the use of supplements
and APOE4. The PMRP dietary data can benefit studies of gene-environment interactions and the development of
common diseases.
Background
With the completion of the Human Genome Project,
the laboratory tools to quantify genetic variation in
human populations exist. Analyzing genetic variation
could lead to the discovery of genetic predictors of dis-
ease. In addition to those predictors, it is important to
quantify gene-environment interactions that modify
genetic associations. Dietary intake is associated with
multiple health outcomes and is one of the critical,
potentially modifiable, environmental exposures to con-
sider in gene-environment studies [1]. Food frequency
questionnaires (FFQ) are the most cost-effective tool to
measure usual dietary intake in large cohort studies, but
caution must be taken with the interpretation and use
of macronutrient data from FFQ [1]. Interactions invol-
ving alcohol intake as an environmental factor have
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certain health outcomes [2]. Another common, modifi-
able, environmental risk factor for consideration in
gene-environment studies is smoking; dietary intake has
been shown to vary by smoking status [3].
Apolipoprotein E (APOE) is one of the most com-
monly researched genes in studies of gene-environment
interactions. Through its function as a ligand and its
involvement with chylomicrons, very-low density lipo-
proteins (VLDL), and high-density lipoproteins (HDLs),
APOE helps maintain cholesterol and fat levels in the
body [4]. The APOE gene has three alleles, one of
which is E4. The E4 allele has been associated with both
coronary heart disease (CHD) and early onset of Alzhei-
mer’s disease [5]. Total cholesterol and LDL cholesterol
levels in general are highest in people who have an E4
allele [6,7]. Some studies have suggested that APOE4
carriers who are smokers are at increased risk for coron-
ary heart disease compared to non-smokers [5].
The Personalized Medicine Research Project (PMRP)
is a population-based DNA, plasma and serum biobank
designed to facilitate genetic epidemiology and pharma-
cogenetic studies [8-11]. The comprehensive medical
record of the Marshfield Clinic is ideal for the identifica-
tion of affected cases and appropriate controls; however,
limited information about personal exposure is collected
in a standardized fashion in the context of routine clini-
cal care. Therefore, assessments of known, potentially
modifiable, risk factors for disease were included in the
study protocol. They include smoking status, alcohol
intake, and a detailed FFQ and physical activity ques-
tionnaire. The purpose of this paper is to describe the
PMRP biobank as a resource for gene-diet studies, to
quantify the extent to which smoking status, alcohol
consumption, and the APOE genotype are associated
with dietary intake in the population, and to explain
how these factors may need to be considered as co-
variants in future gene-nutrient studies.
Methods
Personalized Medicine Research Project (PMRP)
Details of the PMRP have been published previously
[8-11]. In summary, the project was designed to establish
a large biobank consisting of DNA, plasma and serum
from a large representative sample. Since central Wiscon-
sin has a relatively stable population and the majority of
residents receive care at a Marshfield Clinic, the geo-
graphic area is ideal for research over a long period of
time. Participants that were invited were residents of at
least 18 years of age, living in one of 19 zip-codes sur-
rounding Marshfield, WI, and the vast majority received
most of their medical care in the Marshfield Clinic sys-
tem. After subjects have signed the written consent form,
which allows access to their comprehensive Marshfield
Clinic medical record, subjects complete a brief question-
naire about demographics, smoking status, alcohol
intake, and health history. DNA, plasma, and serum sam-
ples were extracted and stored from whole blood. To
extract the DNA, the Gentra’s AUTOPURE
® system was
used. White blood cells were isolated and lysed; through
multiple steps of centrifugation and decanting, DNA was
obtained, washed and stored at -80°C [8]. All procedures
were reviewed and approved by the Marshfield Clinic
Institutional Review Board.
Quantification of dietary intake
The study protocol was amended after nearly 18,000
subjects were enrolled in PMRP to include usual dietary
intake and physical activity. Usual dietary intake was
measured using the validated National Cancer Institute
124-item Diet History Questionnaire (DHQ) [12-17].
For those subjects already enrolled, the DHQ was
mailed out, with a second mailing and follow-up phone
calls as needed to increase the participation rate. The
completed questionnaires were scanned and nutrient
files were created using the software package Diet*Calc
(http://riskfactor.cancer.gov/DHQ/dietcalc/). Question-
naires with more than half of the pages or items not
complete were excluded from analysis. Standard units
were used. ATE CSFII refers to the units for vitamin E.
CSFII stands for Continuing Survey of Food Intakes by
Individuals; ATE stands for alpha-tocopherol equivalent,
which is a form of vitamin E absorbed by humans. IU
and RE refer to the units for measuring vitamin A. IU
stands for international units, and RE stands for retinol
equivalents.
Quantification of APOE4 genotype
Matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry was used to genotype
the polymorphisms of the APOE gene. PCR reactions,
which used primers designed by the Assay Designer 2.05-
software from Sequenom, amplified designated regions of
DNA. Primer extension reactions were performed to gen-
erate allele-specific products that are one base longer
than the original primer. The products were placed onto
a matrix arrayed silicon chip and analyzed by a MALDI-
TOF mass spectrometer and Sequenom SpectroTYPER
3.4 software. The mass spectrometer determines alleles
based on different molecular weights [11].
Statistical analyses
Preliminary analyses included tabular and graphical
summaries describing participant demographics, dietary
intake, and APOE genotypes. In the primary study ana-
lyses we analyze dietary intake for associations with
body size (BMI), smoking status and APOE4, while con-
trolling for expected age and gender differences.
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gate the plausibility and consistency of potential associa-
tions, and to identify potential interactions and
confounding. Group comparisons of dietary intake stra-
tified by gender and age were conducted using rank-
based methods (Wilcoxon and Kruskal-Wallis tests).
Analyses were conducted using SAS
® (version 9.2, SAS
Inc., Cary, NC). Results werec o n s i d e r e ds tatistically
significant at the 5% level (p < 0.05) without adjustment
for multiple comparisons.
Results
The response rate to the mailed questionnaires was
62.8% for subjects who could still be contacted (alive
with known address). Approximately 3% of participants
could not be located and 4% were deceased. Figure 1
Avoid Future 
Contact Code 
n=160 0.8% 
Valid Attempts 
n=18,488 
94.4% 
Ineligible* 
n=126 
0.6% 
No n=490 
2.7% 
Yes n=17,998 
97.4% 
Deliverable? 
Total in Cohort 
n=19,579 
Deceased*** 
n=805 
n=4.1% 
No n=6693 
37.2% 
11,305 
62.8% 
No n=139** 
1.2% 
n=11,116 
98.8% 
Completed? 
Useable? 
Figure 1 Diagram of DHQ mailing for PMRP dietary cohort as of September 16, 2009. The diagram includes participants enrolled on or
before 2/3/09. *nursing home and non-English speaking, **too many missing fields on the DHQ.
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participants. The 11,166 with dietary information ranged
in age from 18 to 98 years (mean 54.9 years) and 6821
(61%) were female. Demographic characteristics of the
dietary cohort and a comparison with non-responders
are summarized in Table 1. Responders were more likely
to be female, older, and never smokers.
Dietary intake varied by age, gender, smoking and the
E4 allele. Trends seen within data are statistically signifi-
cant, unless otherwise noted. Table 2 compares the per-
cent use of various supplements between females and
males of different age groups. The percent use of sup-
plements for females increases as age group increases.
Over fifty percent of women in each age group consume
Table 1 Descriptive characteristics of the dietary cohort and comparison with non-responders
Males Females Overall Non-responders
Subjects (n %) 4,345 39% 6,821 61% 11,166 8,413 52% Female
Median age (yr) 57.1 53.4 54.9 46.4
Minimum 18 18 18 18
Maximum 96 98 98 103
Diabetes (n %) 769 18% 904 13% 1673 15% 1250 15%
Smoking history (n %)
Never 2024 47% 4211 62% 6235 56% 4298 51%
Current 655 15% 983 14% 1638 15% 2065 25%
Other or unknown 1666 38% 1627 24% 3293 29% 2050 24%
E4 genotype (n %) 1198 28% 1750 26% 2948 26% 2271 27%
Median BMI (kg/m
2) 28.7 27.8 28.2 27.8
Minimum 14.7 15.0 14.7 14.9
Maximum 71.1 69.9 71.1 66.4
Median HDL (mg/dL) 43.0 53.5 49.0 46.0
Minimum 16.0 15.0 15.0 11.0
Maximum 135.0 147.0 147.0 141.0
Table 2 Percent use of supplements by gender and age in the Personalized Medicine Research Project
Females Males
Age Group 18-39 40-59 60+ Age Group 18-39 40-59 60+
N* 1644 2645 2512 N* 824 1620 1900
% use % use % use % use % use % use
Vit. A IU 59.6 65.1 71.2 Vit. A IU 38.3 47.3 56.6
Vit. A RAE 59.6 65.1 71.2 Vit. A RAE 38.3 47.3 56.6
Beta Car. 59.0 64.7 70.7 Beta Car. 37.9 47.1 56.6
Vit. E 60.3 68.9 75.6 Vit. E 38.8 49.4 60.4
Vit. C 65.2 72.5 76.6 Vit. C 44.7 53.4 62.5
Thiamin 59.5 66.6 71.6 Thiamin 38.0 47.7 57.4
Riboflavin 59.5 66.6 71.6 Riboflavin 38.0 47.7 57.4
Niacin 59.7 67.0 72.1 Niacin 38.2 48.3 58.6
Vit. B6 59.8 67.4 72.5 Vit. B6 38.3 48.0 58.3
Folic Acid 60.2 65.3 71.7 Folic Acid 38.1 47.3 57.9
Vit. B12 58.7 64.2 70.0 Vit. B12 37.6 46.7 56.1
Calcium 27.8 55.0 69.7 Calcium 13.5 17.3 30.9
Magnesium 54.1 60.0 61.1 Magnesium 32.9 42.3 48.8
Iron 56.5 61.9 63.4 Iron 33.7 42.7 50.8
Zinc 54.8 61.2 62.7 Zinc 34.0 43.3 50.5
Copper 54.1 60.0 61.1 Copper 32.9 42.3 48.8
Vit. D 58.7 64.2 70.0 Vit. D 37.6 46.7 56.1
Selenium 0.5 1.6 2.1 Selenium 0.2 2.2 5.1
*N refers to the total number of females or males within the particular age group.
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comparing males and females in the same age group,
the percent-use of the various supplements is lower in
males than in females. Vitamin C supplements are con-
sumed most frequently by both females and males.
Tables 3 and 4 compare the dietary intake between
different age groups of females (Tables 3) and males
(Table 4). Supplement-use summaries for the subset
who use supplements are list e da tt h eb o t t o mo fe a c h
table. The results suggest that with increasing age in
females, food energy, total fat, cholesterol, protein, and
alcohol intake decreases. Conversely, as women age, the
average supplement intake increased. Similar trends
were observed in males, regarding the mean and median
intake of food energy, total fat, cholesterol, protein, alco-
hol, and supplement intake.
Tables 5, 6 and 7 illustrate supplement use stratified by
age group, gender, smoking, and E4 allele status. Compar-
ing females on smoking status alone, the nonsmokers gen-
erally consume more dietary supplements throughout all
age groups. This similar trend is seen in males as well.
The data show, once again, that females had more supple-
ment use percentages than males when comparing relative
age groups. Differences in supplement use are seen
between those that have the E4 allele and those that do
not. In the nonsmoking females, those with the E4 allele
had higher supplement intake than nonsmokers without
E4. Current smoking females with E4 have a higher
Table 3 Dietary intake in females by age in the Personalized Medicine Research Project
Age Group 18-39 40-59 60+
N* Mean Median N* Mean Median N* Mean Median K-W Test p-value
Food energy (kcal) 2147 1859.5 1637.4 2752 1674.7 1522.7 1997 1415.5 1341.1 < 0.001
Total fat (g) 2147 65.2 56.1 2752 61.6 53.8 1997 51.3 46.0 < 0.001
Cholesterol (mg) 2147 199.3 171.4 2752 185.0 161.7 1997 154.3 137.3 < 0.001
Protein (g) 2147 71.6 64.2 2752 67.3 61.7 1997 54.5 50.8 < 0.001
Alcohol (g) 2147 6.6 2.1 2752 5.9 1.4 1997 3.1 0.6 < 0.001
Vitamin A (IU CSFII) 2147 8958.8 6375.6 2752 9921.8 7354.3 1997 8549.4 6695.0 < 0.001
Vitamin A (mcg RE CSFII) 2147 1264.8 1003.5 2752 1324.5 1096.7 1997 1157.6 999.3 < 0.001
Vitamin E (mg ATE CSFII) 2147 8.3 6.9 2752 8.4 7.3 1997 7.5 6.6 < 0.001
Vitamin C (mg) 2147 134.6 101.3 2752 127.1 104.3 1997 124.5 108.2 < 0.065
Zinc (mg) 2147 11.0 9.8 2752 10.4 9.5 1997 8.7 8.1 < 0.001
Selenium (mcg) 2147 86.2 76.4 2752 81.2 74.0 1997 67.0 62.1 < 0.001
Total Vitamin A Activity (mcg) 2147 838.4 719.7 2752 828.2 719.9 1997 721.8 659.8 < 0.001
Beta Carotene 2147 3198.6 2055.7 2752 3657.3 2524.0 1997 3101.7 2276.5 < 0.001
Lutein|Zeaxanthin (mcg NDS) 2147 2444.7 1643.3 2752 2467.9 1727.9 1997 1998.6 1474.5 < 0.001
Lycopene (mcg NDS R) 2147 7726.0 5611.2 2752 6815.3 4998.7 1997 6096.7 4022.5 < 0.001
Beta Carotene Equivalents (mcg) 2147 3701.3 2373.0 2752 4237.7 2899.1 1997 3599.2 2632.4 < 0.001
Vitamin E Total 2147 7.8 6.4 2752 7.9 6.7 1997 6.7 5.9 < 0.001
Supp. Vitamin A (IU) 2147 2094.6 331.8 2752 2928.0 3571.4 1997 3496.9 5000.0 < 0.001
Supp. Vitamin A (mcg RAE) 2147 628.4 99.6 2752 878.4 1071.4 1997 1049.1 1500.0 < 0.001
Supp. Beta Carotene 2147 246.8 39.8 2752 339.6 428.6 1997 410.7 600.0 < 0.001
Supp. Vitamin E 2147 16.8 4.4 2752 58.5 20.1 1997 78.0 20.1 < 0.001
Supp. Vitamin C 2147 81.1 17.1 2752 150.7 60.0 1997 176.8 60.0 < 0.001
Supp. Zinc 2147 6.1 1.0 2752 8.6 10.7 1997 9.2 15.0 < 0.001
Supp. Selenium 2147 0.3 0.0 2752 0.8 0.0 1997 0.8 0.0 < 0.001
Supplement Users Only
Supp. Vitamin A (IU) 992 3497.2 5000.0 1722 4182.1 5000.0 1789 4843.7 5000.0 < 0.001
Supp. Vitamin A (mcg RAE) 992 1049.2 1500.0 1722 1254.6 1500.0 1789 1453.1 1500.0 < 0.001
Supp. Beta Carotene 982 410.2 600.0 1712 492.9 600.0 1775 572.1 600.0 < 0.001
Supp. Vitamin E 1003 24.6 20.1 1823 74.1 20.1 1900 100.0 20.1 < 0.001
Supp. Vitamin C 1085 115.5 60.0 1917 188.4 60.0 1924 229.1 60.0 < 0.001
Supp. Zinc (mg) 900 1.4 2.0 1587 1.6 2.0 1535 1.8 2.0 < 0.001
Supp. Selenium (mcg) 9 42.9 42.9 43 42.9 42.9 53 42.9 42.9 1.000
*N refers to the total number of participants per age group.
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relatively consistent throughout all age groups in females.
The data show some inconsistencies between males and
females. In nonsmoking males between ages 18-39, those
with E4 have higher percent use than those without E4; in
the same age group, smokers without the E4 allele had
higher use of supplements. In the other two age groups,
nonsmoking males with E4 have lower percent use of sup-
plements than those without E4. Current smoking males
with E4 had a lower percent use than those without E4.
This trend is seen in current smokers among each age
group in males. Supplement use by E4 differed between
genders. In general, females with E4 had higher supple-
ment use percentages, and males with E4 had lower sup-
plement use percentages compared to those without E4.
Table 8 compares the dietary intake between smok-
ing and nonsmoking females and males. For females,
the data suggest that the dietary intake for food
energy, total fat, cholesterol, alcohol, vitamin E (mg
ATE CSFII), selenium, and lycopene was higher in
smokers versus nonsmokers. Furthermore, the dietary
intake for vitamin A (IU CSFII), vitamin A (mcg RE
CSFII), and vitamin C was higher in nonsmokers than
in smokers. No differences were seen in supplement
intake between the two groups. Differences can also be
seen between smokers and nonsmokers when compar-
ing 25% and 75% quartile values. The results regarding
smoking and dietary intake for males were not statisti-
cally significant. Nonsmokers generally consumed heal-
thier diets, as evidenced by using more supplements,
consuming higher dietary vitamin C, and consuming
less alcohol.
Tables 8 and 9 illustrate the supplement intake
between females (Table 9) and males (Table 10)
Table 4 Dietary intake in males by age in the Personalized Medicine Research Project
Age Group 18-39 40-59 60+
N* Mean Median N* Mean Median N* Mean Median K-W Test p-value
Total fat (g) 1105 99.2 85.9 1764 87.0 74.7 1515 69.6 61.9 < 0.001
Cholesterol (mg) 1105 304.0 258.1 1764 263.1 226.1 1515 214.9 186.8 < 0.001
Protein (g) 1105 106.0 91.1 1764 91.7 81.3 1515 71.2 64.4 < 0.001
Alcohol (g) 1105 21.4 5.1 1764 15.5 3.5 1515 10.2 1.8 < 0.001
Vitamin A (IU CSFII) 1105 9292.7 6715.6 1764 9490.8 7456.3 1515 8731.1 6842.3 < 0.001
Vitamin A (mcg RE CSFII) 1105 1442.2 1152.8 1764 1384.7 1201.5 1515 1270.6 1086.9 < 0.001
Vitamin E (mg ATE CSFII) 1105 10.9 8.8 1764 10.2 8.7 1515 9.0 7.8 < 0.001
Vitamin C (mg) 1105 157.3 113.0 1764 137.4 111.4 1515 125.8 107.5 < 0.034
Zinc (mg) 1105 16.3 14.0 1764 14.3 12.6 1515 11.6 10.3 < 0.001
Selenium (mcg) 1105 130.9 114.0 1764 116.1 102.4 1515 92.1 83.5 < 0.001
Total Vitamin A Activity (mcg) 1105 1048.6 862.2 1764 944.1 838.1 1515 848.5 733.7 < 0.001
Beta Carotene 1105 3111.2 1971.9 1764 3290.3 2335.0 1515 3035.9 2195.7 < 0.001
Lutein|Zeaxanthin (mcg NDS) 1105 2640.6 1740.4 1764 2368.8 1773.8 1515 2140.5 1544.8 < 0.001
Lycopene (mcg NDS R) 1105 10491 7941.1 1764 9438.5 6621.3 1515 7770.7 5163.8 < 0.001
Beta Carotene Equivalents (mcg) 1105 3571.6 2266.4 1764 3818.0 2697.1 1515 3521.6 2538.3 < 0.001
Vitamin E Total 1105 10.0 8.1 1764 9.3 8.0 1515 7.9 6.8 < 0.001
Supp. Vitamin A (IU) 1105 1222.9 0.0 1764 2258.9 82.1 1515 2806.4 3571.4 < 0.001
Supp. Vitamin A (mcg RAE) 1105 366.9 0.0 1764 677.7 24.6 1515 841.9 1071.4 < 0.001
Supp. Beta Carotene 1105 144.1 0.0 1764 264.9 9.9 1515 327.5 428.6 < 0.001
Supp. Vitamin E 1105 11.6 0.0 1764 35.9 2.4 1515 50.5 20.1 < 0.001
Supp. Vitamin C 1105 54.8 0.0 1764 106.3 17.1 1515 130.8 60.0 < 0.001
Supp. Zinc 1105 3.8 0.0 1764 6.6 0.0 1515 7.8 0.0 < 0.001
Supp. Selenium 1105 0.2 0.0 1764 1.2 0.0 1515 2.2 0.0 < 0.001
Supplement Users Only
Supp. Vitamin A (IU) 316 3059.8 3571.4 766 4229.3 5000.0 1075 4930.3 5000.0 < 0.001
Supp. Vitamin A (mcg RAE) 316 917.9 1071.4 766 1268.8 1500.0 1075 1479.1 1500.0 < 0.001
Supp. Beta Carotene 312 360.5 428.6 763 494.1 600.0 1076 579.4 600.0 < 0.001
Supp. Vitamin E 320 22.9 14.4 801 61.6 20.1 1147 83.4 20.1 < 0.001
Supp. Vitamin C 368 115.6 60.0 865 173.2 60.0 1187 212.1 60.0 < 0.001
Supp. Zinc (mg) 271 1.2 1.4 685 1.6 2.0 927 1.9 2.0 < 0.001
Supp. Selenium (mcg) 2 42.9 42.9 36 42.9 42.9 96 42.9 42.9 1.000
*N refers to the total number of participants per age group.
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status, and E4 in subjects aged 18-39 in the Personalized
Medicine Research Project
Never Smoked Current Smokers
With E4 No E4 With E4 No E4
Females
N* 293 775 104 296
% Use % Use % Use % Use
Vit. A IU 68.9 61.4 49.0 48.0
Vit. A RAE 68.9 61.4 49.0 48.0
Beta Car. 68.3 60.5 49.0 48.3
Vit. E 69.6 61.9 51.0 49.0
Vit. C 73.0 66.7 52.9 53.7
Thiamin 68.3 60.9 49.0 48.6
Riboflavin 68.3 60.9 49.0 48.6
Niacin 68.3 61.4 49.0 48.6
Vit. B6 68.3 61.4 49.0 49.0
Folic Acid 67.9 62.1 50.0 49.0
Vit. B12 67.9 60.1 48.1 48.0
Calcium 32.4 25.0 27.9 25.0
Magnesium 62.1 55.4 44.2 44.9
Iron 63.1 57.5 45.2 49.0
Zinc 63.1 56.0 45.2 45.6
Copper 62.1 55.4 44.2 44.9
Vit. D 67.9 60.1 48.1 48.0
Selenium 0.0 1.0 0.0 0.3
Males
N* 125 377 59 156
% Use % Use % Use % Use
Vit. A IU 40.8 39.5 30.5 35.9
Vit. A RAE 40.8 39.5 30.5 35.9
Beta Car. 42.4 38.7 28.8 35.3
Vit. E 40.8 39.5 33.9 37.2
Vit. C 46.4 43.8 40.7 46.8
Thiamin 40.8 38.7 30.5 35.9
Riboflavin 40.8 38.7 30.5 35.9
Niacin 41.6 38.7 32.2 35.9
Vit. B6 40.8 38.7 32.2 36.5
Folic Acid 40.8 38.7 32.2 35.9
Vit. B12 40.8 38.7 28.8 35.3
Calcium 16.0 11.9 15.3 12.8
Magnesium 34.4 33.7 25.4 30.8
Iron 34.4 33.7 30.5 33.3
Zinc 35.2 34.7 30.5 31.4
Copper 34.4 33.7 25.4 30.8
Vit. D 40.8 38.7 28.8 35.3
Selenium 0.0 0.30 1.70 0.0
*N refers to the number of participants.
Table 6 Percent use of supplements by gender, smoking
status, and E4 in subjects aged 40-59 in the Personalized
Medicine Research Project
Never Smoked Current Smokers
With E4 No E4 With E4 No E4
Females
N* 426 1186 105 306
% Use % Use % Use % Use
Vit. A IU 70.9 64.3 65.7 57.8
Vit. A RAE 70.9 64.3 65.7 57.8
Beta Car. 70.4 63.8 65.7 56.9
Vit. E 74.2 68.0 65.7 61.1
Vit. C 78.4 72.2 71.4 64.1
Thiamin 73.5 65.5 67.6 58.5
Riboflavin 73.5 65.5 67.6 58.5
Niacin 73.9 65.9 67.6 58.5
Vit. B6 73.5 66.6 69.5 59.5
Folic Acid 71.4 64.6 67.6 57.5
Vit. B12 70.2 63.4 65.7 56.9
Calcium 59.9 55.6 42.9 43.8
Magnesium 67.1 58.9 56.2 53.6
Iron 68.3 61.4 57.1 54.9
Zinc 67.8 59.9 57.1 54.2
Copper 67.1 58.9 56.2 53.6
Vit. D 70.2 63.4 65.7 56.9
Selenium 1.9 1.5 1.9 1.0
Males
N* 230 624 91 215
% Use % Use % Use % Use
Vit. A IU 46.1 47.1 41.8 46.0
Vit. A RAE 46.1 47.1 41.8 46.0
Beta Car. 46.1 47.1 38.5 46.5
Vit. E 47.8 49.5 40.7 47.4
Vit. C 50.9 53.0 49.5 51.6
Thiamin 45.7 47.6 38.5 47.0
Riboflavin 45.7 47.6 38.5 47.0
Niacin 45.7 48.2 38.5 47.9
Vit. B6 46.5 47.6 39.6 47.0
Folic Acid 46.5 47.1 38.5 46.5
Vit. B12 45.7 46.8 37.4 46.0
Calcium 10.4 17.8 13.2 15.3
Magnesium 43.0 41.5 33.0 41.9
Iron 43.0 42.0 34.1 41.9
Zinc 43.9 42.1 35.2 42.8
Copper 43.0 41.5 33.0 41.9
Vit. D 45.7 46.8 37.4 46.0
Selenium 2.2 1.4 2.2 2.8
*N refers to the number of participants.
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gest that females with the E4 allele have higher supple-
ment intake than those without it; however, when
looking at the “supplement users only” data, there is
little to no difference by E4 status. As for males, the
data suggest that those without the E4 allele have
higher supplement intake. With some exceptions, the
same general trend is seen within the “supplement
users only” data.
Discussion
The dietary intake of participants in the Personalized
Medicine Research Project (PMRP) is a useful resource
to assist in studies regarding gene-diet interactions. Sta-
tistically significant findings were seen when analyzing
the PMRP dietary data for differences associated with
smoking, alcohol consumption, and the APOE genotype.
The National Health and Nutrition Examination Sur-
vey (NHANES) is a survey that documents dietary
intake on a yearly basis. Comparing the PMRP dietary
intake of macronutrients with that of NHANES, the
PMRP dietary intake is relatively similar. In ages eigh-
teen and above, percent energy from protein, carbohy-
drates, total fat, and saturated fat are similar between
the PMRP and NHANES. NHANES data revealed
slightly higher food energy, cholesterol, natural folate,
and sodium intake. PMRP intake was significantly
higher for calcium [18]. This finding could be due to
the higher consumption of dairy foods and vegetables
associated the farming in Wisconsin.
Differences have been seen in dietary intake between
smokers and nonsmokers. Interactions between diet and
smoking can lead to negative health outcomes. Findings
of previous studies suggest that smokers consume less
fiber, vegetables, whole grains, fruits but more bacon/
luncheon meats, whole milk, and calories in general [3].
Smokers also are less likely than nonsmokers to con-
sume vitamins, minerals and/or supplements [3]. Our
results are generally consistent with previous findings.
I nP M R P ,w o m e nw h os m o k eh a v eal o w e ri n t a k eo f
supplements and vitamins, and a higher intake in food
energy, fat, cholesterol, and protein. Similarly, supple-
ment intake was lower and alcohol consumption was
higher in smoking males.
Studies have shown the APOE gene to be associated
with increased risk for coronary heart disease (CHD)
and Alzheimer’s Disease. Smoking increases the risk for
CHD alone, but its interaction with the APOE4 geno-
type can cause an even higher risk [2]. This demon-
strates a possible gene-environment interaction. Our
findings suggest that females with the E4 allele have
higher supplement intake and smokers with the E4 allele
have slightly lower use. Males with the E4 allele have
lower supplement intake, but higher use is seen in non-
smokers. These data suggest that people may have
started supplement use to prevent diseases for which
they have in increased risk (possibly due to family his-
tory) and these diseases are associated with APOE. Vita-
min E supplementation has been shown to decrease the
Table 7 Percent use of supplements by gender, smoking
status, and E4 in subjects aged 60 and older in the
Personalized Medicine Research Project
Never Smoked Current Smokers
With E4 No E4 With E4 No E4
Females
N* 374 1157 39 133
% Use % Use % Use % Use
Vit. A IU 73.3 71.3 71.8 60.9
Vit. A RAE 73.3 71.3 71.8 60.9
Beta Car. 72.7 70.7 71.8 61.7
Vit. E 78.3 76.2 74.4 66.9
Vit. C 79.9 76.1 74.4 72.2
Thiamin 74.3 71.6 71.8 61.7
Riboflavin 74.3 71.6 71.8 61.7
Niacin 74.3 72.4 71.8 61.7
Vit. B6 74.9 72.5 71.8 62.4
Folic Acid 74.1 71.3 71.8 63.9
Vit. B12 72.5 69.8 71.8 60.2
Calcium 68.2 72.0 56.4 58.6
Magnesium 64.2 60.3 64.1 51.1
Iron 65.8 62.9 64.1 54.1
Zinc 65.0 62.1 66.7 51.9
Copper 64.2 60.3 64.1 51.1
Vit. D 72.5 69.8 71.8 60.2
Selenium 1.6 2.0 0.0 3.8
Males
N* 190 477 33 101
% Use % Use % Use % Use
Vit. A IU 47.9 57.9 39.4 56.4
Vit. A RAE 47.9 57.9 39.4 56.4
Beta Car. 47.9 58.1 39.4 57.4
Vit. E 53.7 60.6 45.5 57.4
Vit. C 54.2 63.5 48.5 61.4
Thiamin 48.4 59.5 39.4 56.4
Riboflavin 48.4 59.5 39.4 56.4
Niacin 51.1 60.4 39.4 57.4
Vit. B6 48.4 60.6 45.5 57.4
Folic Acid 48.4 58.7 45.5 57.4
Vit. B12 47.4 57.2 39.4 56.4
Calcium 26.8 32.1 33.3 29.7
Magnesium 40.5 50.1 36.4 48.5
Iron 42.1 52.4 36.4 50.5
Zinc 42.1 52.0 39.4 49.5
Copper 40.5 50.1 36.4 48.5
Vit. D 47.4 57.2 39.4 56.4
Selenium 4.7 6.5 3.0 1.0
*N refers to the number of participants.
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directly to consumers for this purpose.
One strength of the PMRP dietary intake data is the
size of the cohort that the data includes. The rela-
tively high response rate is another strength of the
resource. However, there were some response limita-
tions. For early participants, dietary data were
collected several years after their initial enrollment.
The initial 17,000 participants were enrolled within
the first eighteen months after the project began in
2002. The first set of mailings was not sent until
2006. Approximately 4% of participants were deceased
by the time the DHQs were mailed. 2.7% of partici-
pants were not able to be contacted. Males were less
Table 8 Dietary intake by gender and smoking status in the Personalized Medicine Research Project. The total number
of participants who smoked and never smoked is indicated by “N” beneath the respective category
Females
Never Smoked Smoked 100+
N* 4262 2538
25% Median 75% 25% Median 75% Wilcoxon p-value
Food energy (kcal) 1092.3 1468.8 1942.1 1146.3 1539.9 2066.2 < 0.001
Total fat (g) 35.7 51.2 72.3 37.6 54.8 77.2 < 0.001
Cholesterol (mg) 102.8 153.8 220.1 109.6 164.2 235.3 < 0.001
Protein (g) 42.4 58.6 78.3 42.9 60.0 81.1 0.056
Alcohol (g) 0.1 1.1 3.3 0.3 1.7 6.3 < 0.001
Vitamin A (IU CSFII) 4394.1 6915.6 11608 4104.1 6639.4 11198 0.002
Vitamin A (mcg RE CSFII) 703.1 1051.3 1563.0 654.6 1005.5 1536.2 0.003
Vitamin E (mg ATE CSFII) 4.7 6.8 9.9 4.8 7.2 10.5 0.007
Vitamin C (mg) 69.7 107.1 158.2 63.2 100.4 157.4 < 0.001
Zinc (mg) 6.6 9.1 12.1 6.6 9.3 12.4 0.089
Selenium (mcg) 50.5 70.2 94.2 52.4 72.9 99.2 0.002
Total Vitamin A Activity (mcg) 479.9 706.7 989.6 451.1 692.1 1000.1 0.206
Beta Carotene 1374.5 2316.2 4265.4 1267.5 2266.6 4176.5 0.060
Lutein|Zeaxanthin (mcg NDS) 1029.3 1636.6 2579.3 1002.5 1615.4 2619.1 0.506
Lycopene (mcg NDS R) 3026.7 4815.3 7901.4 3194.0 5075.2 8470.1 0.003
Beta Carotene Equivalents (mcg) 1586.3 2689.2 4912.3 1468.6 2609.5 4793.5 0.026
Vitamin E Total 4.4 6.3 9.2 4.4 6.5 9.6 0.026
Males
Never Smoked Smoked 100+
N* 2045 2233
25% Median 75% 25% Median 75% Wilcoxon p-value
Food energy (kcal) 1499.7 2051.0 2772.5 1426.6 1955.4 2720.8 0.050
Total fat (g) 50.4 73.9 104.4 49.2 71.2 104.9 0.156
Cholesterol (mg) 147.1 222.4 324.5 147.5 216.6 326.0 0.685
Protein (g) 57.6 79.3 110.3 54.1 75.5 105.4 0.001
Alcohol (g) 0.6 2.8 10.0 0.6 3.5 15.2 0.001
Vitamin A (IU CSFII) 4734.1 7164.8 11634 4505.0 6892.0 10910 0.054
Vitamin A (mcg RE CSFII) 777.6 1179.8 1760.9 744.9 1109.3 1652.2 0.002
Vitamin E (mg ATE CSFII) 5.8 8.4 12.1 5.7 8.3 12.2 0.342
Vitamin C (mg) 73.1 113.1 176.0 67.8 107.5 167.6 0.004
Zinc (mg) 8.9 12.2 17.4 8.5 11.8 16.7 0.006
Selenium (mcg) 71.3 98.8 136.8 68.2 96.8 134.2 0.148
Total Vitamin A Activity (mcg) 554.6 834.8 1209.9 523.7 785.4 1154.5 0.001
Beta Carotene 1294.6 2163.3 3954.2 1333.7 2184.9 3822.1 0.813
Lutein|Zeaxanthin (mcg NDS) 1103.4 1737.5 2696.4 1030.2 1633.7 2641.8 0.072
Lycopene (mcg NDS R) 3976.0 6436.8 10382 3846.7 6409.3 10736 0.780
Beta Carotene Equivalents (mcg) 1499.2 2499.0 4593.6 1528.5 2523.0 4431.0 0.705
Vitamin E Total 5.4 7.6 11.1 5.2 7.5 11.1 0.196
*N refers to the number of participants.
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information should be considered, the percentages are
quite low and do not present a strong impact on the
collected data.
Conclusions
Detailed dietary history data are available for more than
11,000 adult participants in a biobank with DNA, plasma
and serum samples linked to a comprehensive electronic
health record. The cohort is representative of the popula-
tion of central Wisconsin. The dietary intake data will be
a valuable resource for studies of gene-environment
interactions. The Diet History Questionnaire should be
followed up with periodic updates to assess changes in
intake over time. The PMRP welcomes collaboration to
enhance and expand gene-environment research.
Table 9 Supplement intake by APOE4 genotype in females in the Personalized Medicine Research Project
With E4 No E4
Nutrient N* Mean S.D. Median N* Mean S.D. Median Wilcoxon p-value
Supp. Vitamin A (IU) 1750 2965.2 2801.5 3571.4 5071 2789.8 2845.7 3571.4 0.006
Supp. Vitamin A (mcg RAE) 1750 889.6 840.4 1071.4 5071 836.9 853.7 1071.4 0.006
Supp. Beta Carotene 1750 350.6 329.0 428.6 5071 325.1 323.0 428.6 0.002
Supp. Vitamin E 1750 52.6 113.6 20.1 5071 50.8 108.8 20.1 0.046
Supp. Vitamin C 1750 140.5 273.5 60.0 5071 134.4 262.3 60.0 0.076
Supp. Thiamin (mg) 1750 1.4 2.0 1.5 5071 1.3 1.9 1.1 0.002
Supp. Riboflavin (mg) 1750 1.3 1.5 1.7 5071 1.2 1.5 1.2 0.002
Supp. Niacin (mg) 1750 13.7 13.4 20.0 5071 12.7 12.9 14.3 0.003
Supp. Vitamin B6 (mg) 1750 4.4 10.6 2.0 5071 4.3 10.8 1.4 0.014
Supp. Folic Acid (mcg) 1750 230.2 191.8 285.7 5071 215.8 194.8 285.7 0.004
Supp. Vitamin B12 (mcg) 1750 3.3 2.8 4.3 5071 3.1 2.8 4.3 0.002
Supp. Vitamin D (mcg) 1750 286.6 365.6 16.6 5071 290.5 371.6 16.6 0.866
Supp. Calcium (mg) 1750 50.8 47.3 71.4 5071 47.1 47.2 28.6 0.003
Supp. Magnesium (mg) 1750 10.4 10.3 12.9 5071 9.9 10.2 12.9 0.111
Supp. Iron (mg) 1750 8.4 8.2 10.7 5071 7.9 8.3 4.3 0.007
Supp. Zinc (mg) 1750 1.0 0.9 1.4 5071 0.9 0.9 0.6 0.003
Supp. Copper (mg) 1750 221.4 186.7 285.7 5071 205.9 188.0 285.7 0.002
Supp. Selenium (mcg) 1750 0.6 4.9 0.0 5071 0.7 5.4 0.0 0.375
Supplement Users Only
Supp. Vitamin A (IU) 1208 4295.6 2377.5 5000.0 3295 4293.5 2450.7 5000.0 0.931
Supp. Vitamin A (mcg RAE) 1208 1288.7 713.3 1500.0 3295 1288.0 735.2 1500.0 0.931
Supp. Beta Carotene 1201 510.9 275.4 600.0 3268 504.4 267.2 600.0 0.558
Supp. Vitamin E 1261 73.1 128.1 20.1 3465 74.3 124.8 20.1 0.468
Supp. Vitamin C 1314 187.2 301.5 60.0 3612 188.6 293.9 60.0 0.262
Supp. Thiamin (mg) 1228 2.0 2.1 1.5 3323 1.9 2.1 1.5 0.841
Supp. Riboflavin (mg) 1228 1.9 1.5 1.7 3323 1.8 1.4 1.7 0.841
Supp. Niacin (mg) 1231 19.5 11.8 20.0 3346 19.2 11.3 20.0 0.857
Supp. Vitamin B6 (mg) 1234 6.2 12.2 2.0 3366 6.5 12.7 2.0 0.634
Supp. Vitamin B12 (mcg) 1220 330.2 140.6 400.0 3310 330.6 142.0 400.0 0.954
Supp. Folic Acid (mcg) 1195 4.9 2.0 6.0 3238 4.8 2.0 6.0 0.697
Supp. Vitamin D (mcg) 941 533.0 342.5 500.0 2727 540.2 349.1 500.0 0.686
Supp. Calcium (mg) 1086 81.9 32.5 100.0 2936 81.4 32.5 100.0 0.681
Supp. Magnesium (mg) 1110 16.4 8.2 18.0 3059 16.5 8.0 18.0 0.290
Supp. Iron (mg) 1107 13.2 6.5 15.0 2998 13.3 6.6 15.0 0.908
Supp. Zinc (mg) 1086 1.6 0.6 2.0 2936 1.6 0.7 2.0 0.681
Supp. Copper (mg) 1195 324.2 133.1 400.0 3238 322.5 133.1 400.0 0.697
Supp. Selenium (mcg) 23 42.9 0.0 42.9 82 42.9 0.0 42.9 1.000
*N refers to the number of participants.
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Table 10 Supplement intake by APOE4 genotype in males in the Personalized Medicine Research Project
With E4 No E4
Nutrient N Mean S.D. Median N Mean S.D. Median Wilcoxon p-value
Supp. Vitamin A (IU) 1198 2068.6 2769.4 0.0 3146 2234.1 2781.4 82.1 0.047
Supp. Vitamin A (mcg RAE) 1198 620.6 830.8 0.0 3146 670.2 834.4 24.6 0.047
Supp. Beta Carotene 1198 239.8 301.6 0.0 3146 262.4 322.6 9.9 0.043
Supp. Vitamin E 1198 34.0 92.0 0.3 3146 35.5 94.2 1.3 0.118
Supp. Vitamin C 1198 95.1 220.8 8.2 3146 105.0 243.7 17.1 0.312
Supp. Thiamin (mg) 1198 0.9 1.5 0.0 3146 0.9 1.6 0.0 0.042
Supp. Riboflavin (mg) 1198 0.8 1.2 0.0 3146 0.9 1.3 0.0 0.042
Supp. Niacin (mg) 1198 9.6 13.0 0.0 3146 10.5 13.8 0.3 0.052
Supp. Vitamin B6 (mg) 1198 2.3 7.4 0.0 3146 2.8 8.4 0.0 0.029
Supp. Folic Acid (mcg) 1198 156.8 189.9 0.0 3146 171.7 194.1 6.6 0.020
Supp. Vitamin B12 (mcg) 1198 2.3 2.8 0.0 3146 2.5 2.8 0.1 0.020
Supp. Vitamin D (mcg) 1198 66.8 199.6 0.0 3146 88.3 228.9 0.0 0.010
Supp. Calcium (mg) 1198 34.2 45.6 0.0 3146 37.4 46.7 0.0 0.029
Supp. Magnesium (mg) 1198 6.7 9.0 0.0 3146 7.4 9.4 0.0 0.022
Supp. Iron (mg) 1198 5.9 8.1 0.0 3146 6.5 8.5 0.0 0.029
Supp. Zinc (mg) 1198 0.7 0.9 0.0 3146 0.7 0.9 0.0 0.029
Supp. Copper (mg) 1198 151.4 185.6 0.0 3146 166.1 189.4 6.6 0.020
Supp. Selenium (mcg) 1198 1.1 6.8 0.0 3146 1.4 7.6 0.0 0.242
Supplement Users Only
Supp. Vitamin A (IU) 568 4362.9 2482.6 5000.0 1589 4423.2 2373.4 5000.0 0.415
Supp. Vitamin A (mcg RAE) 568 1308.9 744.8 1500.0 1589 1327.0 712.0 1500.0 0.415
Supp. Beta Carotene 564 509.4 236.2 600.0 1587 520.2 268.8 600.0 0.653
Supp. Vitamin E 603 67.5 120.6 20.1 1665 67.0 121.0 20.1 0.690
Supp. Vitamin C 652 174.8 275.2 60.0 1768 186.8 300.7 60.0 0.890
Supp. Thiamin (mg) 573 1.8 1.8 1.5 1603 1.8 1.9 1.5 0.363
Supp. Riboflavin (mg) 573 1.7 1.3 1.7 1603 1.8 1.3 1.7 0.363
Supp. Niacin (mg) 583 19.8 12.2 20.0 1628 20.3 12.9 20.0 0.492
Supp. Vitamin B6 (mg) 579 4.8 10.1 2.0 1621 5.4 11.0 2.0 0.217
Supp. Vitamin B12 (mcg) 571 329.0 137.8 400.0 1610 335.6 136.4 400.0 0.244
Supp. Folic Acid (mcg) 558 4.9 2.0 6.0 1574 5.0 1.9 6.0 0.185
Supp. Vitamin D (mcg) 241 331.9 332.1 250.0 738 376.4 339.2 285.7 0.069
Supp. Calcium (mg) 489 83.7 30.8 100.0 1394 84.4 30.9 100.0 0.466
Supp. Magnesium (mg) 503 15.8 6.7 18.0 1431 16.3 7.1 18.0 0.260
Supp. Iron (mg) 505 13.9 6.6 15.0 1437 14.1 7.0 15.0 0.516
Supp. Zinc (mg) 489 1.7 0.6 2.0 1394 1.7 0.6 2.0 0.466
Supp. Copper (mg) 558 325.0 132.2 400.0 1574 331.9 129.1 400.0 0.185
Supp. Selenium (mcg) 31 42.9 0.0 42.9 103 42.9 0.0 42.9 1.000
*N refers to the number of participants.
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